Back to blog
ACLS

Refractory VF in cardiac arrest, what to do? Considerations around the DOSE VF study

Alternative defibrillation in refractory VF: recent evidence shows how double sequential defibrillation can change the

Simon GrosjeanMedico
May 13, 2026
5 min read
204 views
Log in to like
Refractory VF in cardiac arrest, what to do? Considerations around the DOSE VF study
ACLS

Indice

5 min

Management of Refractory Ventricular Fibrillation: Alternative Defibrillation Strategies

The management of out-of-hospital cardiac arrest (OHCA) represents one of the greatest challenges in emergency medicine. Despite advances in resuscitation techniques, overall survival remains low, standing at around 10% in most settings. A recent study published in Resuscitation analyzed the impact of alternative defibrillation strategies on time spent in ventricular fibrillation (VF), providing new interesting perspectives for the treatment of refractory VF.

Historical Evolution of Defibrillation

Electrical defibrillation represents one of the most important advances in cardiac arrest management. From its first documented use in 1947 by Claude Beck during surgery, the technique has evolved significantly. The introduction of biphasic defibrillators in the early 1990s marked an important advance, improving efficacy and reducing myocardial damage compared to previous monophasic defibrillators.

However, despite these technological advances, refractory VF, defined as the persistence of VF after three or more shocks, remains a significant challenge, with particularly low survival rates.

Position in Current Guidelines

Current international guidelines for cardiopulmonary resuscitation maintain a conservative approach regarding alternative defibrillation strategies.

ILCOR (International Liaison Committee on Resuscitation): does not provide specific recommendations on the use of DSED (Double Sequential External Defibrillation) or VC (Vector Change), citing insufficient high-quality evidence.

AHA (American Heart Association): in the 2020 guidelines, mentions DSED and VC as potentially useful strategies in refractory VF, but without a formal recommendation for their routine use.

ERC (European Resuscitation Council): in the 2021 guidelines, recognizes the potential benefit of these alternative strategies, but suggests limiting their use to research settings or specific protocols.

The DOSE VF Study: A Paradigm Shift?

Methodology

The study used a rigorous design:

  • Design: cluster randomized controlled trial
  • Setting: six emergency medical services in Ontario
  • Population: 342 patients with refractory VF
  • Inclusion criteria: persistent VF after three standard shocks
  • Randomization to three arms: standard, VC, DSED

The methodological peculiarity of the study was the detailed analysis of time spent in VF in the 120 seconds following each shock, providing a new perspective on the efficacy of different strategies.

Detailed Results

Beyond the main results, the study highlighted relevant aspects on multiple levels.

Temporal patterns:

  • The reduction in time in VF was most marked in the first two post-randomization shocks
  • The effect tended to decrease with subsequent shocks

Rhythm transitions:

  • DSED: lower probability of persistent VF (29.9%)
  • Standard: higher probability of persistent VF (40.6%)
  • VC: intermediate results

Neurological outcomes:

  • Trend toward better neurological outcomes in the DSED group
  • Possible correlation with reduction in total time in VF

The Role of Timing in DSED: New Analyses and Practical Implications

A recent study published in Resuscitation by Rahimi et al. analyzed the role of timing in double sequential defibrillation (DSD). The study revealed that the optimal interval between the two shocks should be less than 75 milliseconds to maximize defibrillation success.

Main results:

  • VF terminated in 48% of patients with interval < 75 ms
  • In patients with intervals > 75 ms, the VF conversion rate dropped to 24%
  • No significant difference in hospital survival between the two groups

These data suggest that simultaneity of shocks could improve defibrillation efficacy in refractory VF. However, further studies are needed to confirm these results on a large scale.

Pathophysiological Mechanisms

The superior efficacy of alternative strategies can be explained through several mechanisms.

Metabolic effects:

  • Lower depletion of myocardial ATP
  • Reduction in lactate accumulation
  • Preservation of cellular energy reserves

Electrophysiological effects:

  • Overcoming areas of conduction block
  • Modification of transmural voltage gradients
  • Possible interruption of reentry circuits

Hemodynamic effects:

  • Lower total time of low perfusion
  • Reduction of ischemia-reperfusion injury
  • Better preservation of myocardial function

Practical Implications for Prehospital Care

In the context of prehospital emergency care, implementation timing represents a crucial factor. We should consider early use of the procedure in selected cases, without necessarily waiting for the failure of three conventional shocks. This approach could be integrated into local protocols, adapting it to the specificities of the territory.

From a technical standpoint, specific personnel training is fundamental to ensure intervention efficacy. Particular attention must be paid to correct electrode positioning, a determining element for procedure success. It is also essential to minimize interruptions of chest compressions during application, maintaining adequate perfusion.

Efficient resource management completes the operational picture: ensuring availability of additional defibrillators specific for DSD, coordinating the team during the procedure, and optimizing intervention times. Careful organization of these aspects can make the difference in emergency outcomes.

Ongoing Studies and Future Perspectives

Several trials are currently underway that could influence future guidelines.

DOUBLE-D trial (Europe): evaluates DSD after a single failed shock. Potential paradigm shift toward earlier use.

STRAT-DEFI study: comparison of different defibrillation strategies with focus on optimal implementation timing.

DUALDEFIB trial: DSD as initial strategy. Potential revolution in the approach to VF.

Conclusions and Perspectives

The DOSE VF study represents an important step forward in understanding and treating refractory VF. The demonstration that alternative defibrillation strategies reduce time in VF and improve outcomes provides a solid foundation for their use in clinical practice.

However, implementation of these strategies requires updating of operational protocols, specific personnel training, continuous evaluation of results, and possible adjustment of available resources.

While awaiting international guidelines to incorporate this evidence, prehospital emergency services can consider implementing specific protocols based on these alternative strategies, particularly in selected cases of refractory VF. Future research will further clarify their role, potentially modifying the standard approach to defibrillation in out-of-hospital cardiac arrest.


Bibliography

  1. Drennan IR, Dorian P, McLeod S, et al. DOuble SEquential External Defibrillation for Refractory Ventricular Fibrillation (DOSE VF): study protocol for a randomized controlled trial. Trials. 2020;21(1):977. doi:10.1186/s13063-020-04904-z
  1. Link MS, et al. Part 6: Electrical Therapies: Automated External Defibrillators, Defibrillation, Cardioversion, and Pacing: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020.
  1. Nolan JP, et al. European Resuscitation Council Guidelines 2021: Executive Summary. Resuscitation. 2021.
  1. Panchal AR, et al. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020.
  1. Rahimi H, et al. The impact of double sequential shock timings on outcomes during refractory out-of-hospital cardiac arrest. Resuscitation. 2024.
  1. Fowler P, et al. Strategies for Refractory Ventricular Fibrillation: An Update on Current Evidence. Annals of Emergency Medicine. 2023.

Log in to like
🧠

Want to learn more?

Discuss this article with EMSy's AI to get personalized analysis for your profession

EMSy Focus

Discuss this article with EMSy's AI to get personalized insights for your profession

Powered by AI • Personalized answers

About the Author

Simon Grosjean - Medical Doctor (MD) - Author at EMSy

Dr. Simon Grosjean

Medical Doctor (MD)

President & Founder - EMSy S.r.l.

Prehospital Emergency Physician and President of EMSy. Expert in pre-hospital emergency medicine with years of field experience. Creator of EMSy's AI architecture, translating clinical needs into innovative technological solutions.

Author

Simon Grosjean

Physician

Share

EMSy Focus

Discuss this article with EMSy's AI to get personalized insights for your profession

Powered by AI • Personalized answers

Want to stay updated?

Subscribe to receive new articles directly in your email

Medical Disclaimer

This content is provided exclusively for educational and informational purposes for healthcare professionals. It does not replace professional medical consultation, diagnosis, or treatment. Always consult your physician or other qualified healthcare provider for any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you read on this site.

Last updated: March 22, 2025
Author: Simon Grosjean - Physician
Reviewed by: EMSy Medical Review Team